Medications for Pulmonary Hypertension

2 results

  • remodulin - treprostinil injection, solution

    (Treprostinil)
    United Therapeutics Corporation
    Remodulin treats pulmonary arterial hypertension (PAH; WHO Group 1) in adults with NYHA Class II–IV symptoms to reduce exercise-related symptoms. Also indicated for patients transitioning from epoprostenol to slow clinical deterioration.
    Medication Details
    Drug Interactions

  • uptravi - selexipag tablet, coated

    (Selexipag)
    Actelion Pharmaceuticals Us, Inc.
    Uptravi treats pulmonary arterial hypertension (PAH, WHO Group I) in adults and children aged 2 and older. It delays disease progression and reduces the risk of hospitalization for PAH.
    Medication Details
    Drug Interactions